New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 3, 2013
18:05 EDTSRPTSarepta announces $125M at-the-market equity offering
Sarepta Therapeutics entered into an at-the-market equity offering sales agreement with Further Lane Securities, under which Sarepta may, from time to time, offer and sell shares of its common stock having an aggregate value of up to $125M through Further Lane. Sarepta intends to use any proceeds from this offering for general corporate purposes, including for manufacturing scale up for eteplirsen, the planned confirmatory Phase III clinical study of eteplirsen and early development activities related to follow-on Duchenne muscular dystrophy drugs and other programs.
News For SRPT From The Last 14 Days
Check below for free stories on SRPT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 8, 2014
14:44 EDTSRPTInvestors await eteplirsen news from Sarepta amid speculation, TheStreet says
Subscribe for More Information
09:13 EDTSRPTSarepta April volatility increases to 166
Subscribe for More Information
April 7, 2014
11:11 EDTSRPTSarepta said to cancel appearance at Needham conference
Sarepta cancelled its appearance at Needham's conference tomorrow due to "other obligations," a re-tweet by The Street's Adam Feuerstein says, citing a confirmation from the company. Shares of Sarepta moved up 23c to $23.37 following circulation of the tweet.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use